Fibrotic Disorders Associated with Methysergide Therapy for Headache
- 17 February 1966
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 274 (7) , 359-368
- https://doi.org/10.1056/nejm196602172740701
Abstract
THE development of retroperitoneal fibrosis in 27 patients using methysergide for the prevention of headache is the occasion for this report. Irving Beck, of Providence, Rhode Island, was the first to suggest a possible connection between methysergide and retroperitoneal fibrosis in July, 1961, when this condition developed in 1 of his patients, supplied with this drug by one of us. When a second patient taking methysergide for headache was similarly afflicted in November, 1962, the 2 cases were reported.1 Since then, as of October, 1965, our attention has been directed to a total of 27 patients in whom, while they . . .Keywords
This publication has 24 references indexed in Scilit:
- POSSIBLE CARDIAC AND RENO‐VASCULAR COMPLICATIONS OF SANSERT THERAPYHeadache: The Journal of Head and Face Pain, 1965
- AnnouncementsJournal of Investigative Dermatology, 1964
- A case of idiopathic retroperitoneal fibrosis presenting as a systemic collagen diseaseThe American Journal of Medicine, 1964
- Reflex vasomotor abnormalities in the hands of migrainous subjectsJournal of Neurology, Neurosurgery & Psychiatry, 1963
- RETROPERITONEAL VASCULITIS WITH PERIVASCULAR FIBROSISBritish Journal of Urology, 1963
- Acute Idiopathic Retroperitoneal FibrosisAnnals of Surgery, 1961
- Coronary Arteriosclerosis Induced in Young Dogs by Prolonged Intra-aortic Infusions of SerotoninCirculation Research, 1961
- Diffuse idiopathic fibrosisThe American Journal of Surgery, 1961
- Migraine and its Relationship to HypertensionBMJ, 1959
- Superior Vena Caval Obstruction Due to Chronic MediastinitisThorax, 1946